Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

RAS mutations are uncommon in multiple myeloma and other monoclonal gammopathies.

International journal of oncology - 1 Oct 2005

Martín Paloma, Santón Almudena, García-Cosío Mónica, Bellas Carmen

Abstract excerpt

Monoclonal gammopathies are a group of diseases characterised by the proliferation of a single clone of plasma cells that produce a homogeneous monoclonal protein (M protein or myeloma protein) that consist of two heavy polypeptide chains of the same class and subclass and two light polypeptide chains of the same type. Multiple myeloma (MM) and monoclonal gammopathy of undetermined significance (MGUS) are the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow
Share to Bone Marrow Cells
Share to Genes, ras

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Multiple Myeloma

Share to Paraproteinemias

Share to Proteoglycans

Share to Syndecan-1

Source

Identifiers

PMID: 16142319

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

RAS mutations are uncommon in multiple myeloma and other monoclonal gammopathies.PMID 16142319Read ↗

Relevance of Ras gene mutations in the context of the molecular heterogeneity of multiple myeloma.Semantic proximity Read ↗

RAS/RAF landscape in monoclonal plasma cell conditions.Semantic proximity Read ↗

Mutational activation of N- and K-ras oncogenes in plasma cell dyscrasias.Semantic proximity Read ↗

RAS gene mutations in multiple myeloma and related monoclonal gammopathies.Semantic proximity Read ↗

Clinical and biological significance of RAS mutations in multiple myelomaSemantic proximity Read ↗

High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis.Semantic proximity Read ↗

Plasma cell myeloma with RAS/BRAF mutations: Clinicopathologic, molecular genetic features and outcomes of 68 patientsSemantic proximity Read ↗

RAS mutations - for better or for worse in multiple myeloma?Semantic proximity Read ↗

Loss of Heterozygosity and Mutations in the RAS-ERK Pathway Genes in Tumor Cells of Various Loci in Multiple Myeloma.Semantic proximity Read ↗

Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors.Semantic proximity Read ↗

N-ras and p53 gene mutations are very rare events in multiple myeloma.Semantic proximity Read ↗

Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III TrialSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.